GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » PB Ratio

Joinn Laboratories (China) Co (SHSE:603127) PB Ratio : 1.48 (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-29), Joinn Laboratories (China) Co's share price is ¥16.39. Joinn Laboratories (China) Co's Book Value per Share for the quarter that ended in Dec. 2023 was ¥11.04. Hence, Joinn Laboratories (China) Co's PB Ratio of today is 1.48.

The historical rank and industry rank for Joinn Laboratories (China) Co's PB Ratio or its related term are showing as below:

SHSE:603127' s PB Ratio Range Over the Past 10 Years
Min: 1.41   Med: 8.6   Max: 30.02
Current: 1.48

During the past 12 years, Joinn Laboratories (China) Co's highest PB Ratio was 30.02. The lowest was 1.41. And the median was 8.60.

SHSE:603127's PB Ratio is ranked better than
58.1% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11 vs SHSE:603127: 1.48

During the past 12 months, Joinn Laboratories (China) Co's average Book Value Per Share Growth Rate was 1.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 78.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 74.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 50.00% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Joinn Laboratories (China) Co was 108.30% per year. The lowest was 27.20% per year. And the median was 34.40% per year.

Back to Basics: PB Ratio


Joinn Laboratories (China) Co PB Ratio Historical Data

The historical data trend for Joinn Laboratories (China) Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co PB Ratio Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.00 19.18 6.17 3.82 2.15

Joinn Laboratories (China) Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 3.36 2.61 2.17 2.15

Competitive Comparison of Joinn Laboratories (China) Co's PB Ratio

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's PB Ratio falls into.



Joinn Laboratories (China) Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Joinn Laboratories (China) Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=16.39/11.041
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Joinn Laboratories (China) Co  (SHSE:603127) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Joinn Laboratories (China) Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co (SHSE:603127) Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines